BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 4283271)

  • 21. Host immune response to virus-induced tumors. Some recent concepts.
    Aoki T; Chieco-Bianchi L; Plata EJ; Sendo F; Hollis VW; Kudo T
    Prog Exp Tumor Res; 1974; 19():23-36. PubMed ID: 4373781
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biochemistry of histocompatibility alloantigens (author's transl)].
    Muramatsu T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):771-82. PubMed ID: 4140543
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoimmunity and neoplasia. The possible role of C-type viruses.
    Levy JA
    Am J Clin Pathol; 1974 Aug; 62(2):258-80. PubMed ID: 4367272
    [No Abstract]   [Full Text] [Related]  

  • 24. The immune response to virally determined tumor associated antigens.
    Lamon EW
    Biochim Biophys Acta; 1974 Sep; 355(2):149-76. PubMed ID: 4370470
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor immunity.
    Humphrey LJ
    J Surg Res; 1970 Oct; 10(10):493-512. PubMed ID: 4920329
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor.
    Justice A
    Psychol Bull; 1985 Jul; 98(1):108-38. PubMed ID: 2994138
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens.
    Law LW; Rogers MJ; Appella E
    Adv Cancer Res; 1980; 32():201-35. PubMed ID: 6258404
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunodepression by mammalian viruses and plasmodia.
    Salaman MH
    Proc R Soc Med; 1970 Jan; 63(1):11-5. PubMed ID: 4317356
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of X Gf mice with respect to their resistance to oncogensis.
    Goldfeder A
    Trans N Y Acad Sci; 1974 Jan; 36(1):59-77. PubMed ID: 4377184
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental models in cancer immunotherapy.
    Ross DS; Steele G
    J Surg Res; 1984 Nov; 37(5):415-30. PubMed ID: 6208411
    [No Abstract]   [Full Text] [Related]  

  • 31. Virus-induced tumor antigens.
    Habel K
    Curr Top Microbiol Immunol; 1967; 41():85-99. PubMed ID: 4862183
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunology of virus-induced tumours.
    Sjögren HO
    Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunodepression by oncogenic viruses.
    Dent PB
    Prog Med Virol; 1972; 14():1-35. PubMed ID: 4338188
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor-associated membrane antigens and the antitumor immune reactions.
    Levy JP; Kourilsky FM
    Transplant Proc; 1973 Dec; 5(4):1435-40. PubMed ID: 4130056
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterogenization of normal tissues in oncogenesis. A skeptical review.
    Mariani T; Good RA
    Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
    [No Abstract]   [Full Text] [Related]  

  • 37. Blocking antibodies and enhancement.
    Heppner GH
    Ser Haematol; 1972; 5(4):41-66. PubMed ID: 4364363
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.